Vimarsana
Biggest News Aggregation in the World

Pinnacle Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pinnacle Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pinnacle Research Today - Breaking & Trending Today

CSPAN Key Capitol Hill Hearings October 25, 2014 - Vimarsana News

CSPAN Key Capitol Hill Hearings October 25, 2014

Interests out there. I care and ill keep caring. I hoff you. Ask for your vote and hope to see you soon. Thank you, mr. Congressman. Mr. Tarpley without mentioning any of your opponents why should i vote for you . The policies of the federal government are destroying the middle class in this country. We see rising prices, wages that are stagnating, jobs that have been shipped overseas. Right here in our district we see jobs that have been lost over the last ten, 15, 20 years. What is the problem . The problem, ladies and gentlemen, is not that washington is broken. Washington is bought. The pr...

CSPAN Washington This Week October 25, 2014 - Vimarsana News

CSPAN Washington This Week October 25, 2014

The saturation. When i was running a business in arizona, if we play a cbs game against kansas, they were not revenuesharing. We must be big money. 25,000 for a sunday cbs game. But a game against washington 500,000. Bc paid now we have focused so much on the tournament that in College Football for moment, every game is critical. A cautionary tale. You have got 12 games. Youre now watching the media going crazy from ok, whsos in, whos out. It is a sixmonth juggernaut of your stomach being tied. I bought a case of peptobismol. Because you are drinking constantly going, what is going to happen t...

Altimmune, Inc. (NASDAQ:ALT) Q3 2023 Earnings Call Transcript - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Altimmune, Inc. (NASDAQ:ALT) Q2 2023 Earnings Call Transcript - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) Q2 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Pemvidutide Promising for Fatty Liver Disease - Vimarsana News

Pemvidutide Promising for Fatty Liver Disease

Weight loss and multiple improvements in lipid parameters linked to nonalcoholic fatty liver disease were seen in a phase 1 trial.